Outcome after urgent percutaneous coronary interventions in ASSENT-3

Stroke after percutaneous coronary interventions.

n this issue of the Journal, Dukkipati et al. (1) identified the ncidence, predictors, and outcomes of stroke in patients ndergoing percutaneous coronary interventions (PCIs). troke occurred in hospital in 92 of 20,670 patients (0.3%) fter PCI, which is higher than the reported rates of 0.08% o 0.17% after diagnostic catheterization (2). The good news in this report is that brain injury hapened...

Inflammation and restenosis after percutaneous coronary interventions.

The role of inflammation in the development of restenosis after percutaneous coronary interventions has been investigated in several studies. There is an interaction of inflammatory activation and vascular wall response to injury leading to intimal hyperplasia. Percutaneous interventions trigger inflammatory reactions leading to the development of intimal hyperplasia. This reaction is even more...

[Intracoronary inflammatory markers after percutaneous coronary interventions].

OBJECTIVE To analyze intracoronary release of inflammatory markers (IM) after percutaneous coronary interventions (PCI) and compare their concentrations concerning the type of PCI used (rotablator vs. balloon angioplasty). METHODS Twenty-two patients with average age of 60 +/- 11.9 years old, 12 of male sex, with stable coronary disease, submitted to elective treatment of a single coronary le...

Management of patients after percutaneous coronary interventions.

Percutaneous Intervention and Anticoagulation Outcome of Urgent and Elective Percutaneous Coronary Interventions After Pharmacologic Reperfusion With Tenecteplase Combined With Unfractionated Heparin, Enoxaparin, or Abciximab

Christophe L. Dubois, MD,* Ann Belmans, MSC,*† Christopher B. Granger, MD, FACC,‡ Paul W. Armstrong, MD, FACC,§ Lars Wallentin, MD, FACC, Paolo M. Fioretti, MD, FACC,¶ José L. López-Sendón, MD, FACC,# Freek W. Verheugt, MD, FACC,** Jürgen Meyer, MD, FACC,†† Frans Van de Werf, MD, FACC,* on behalf of the ASSENT-3 Investigators Leuven, Belgium; Durham, North Carolina; Edmonton, Canada; Uppsala, S...